Sildenafil Citrate Tablets by Aurobindo Pharma receives a tentative USFDA nod
The company will manufacture and market the tablets used for treating erectile dysfunction and pulmonary arterial hypertension
Aurobindo Pharma has crossed the first line, receiving a tentative approval from the US Food and Drug Administration a temporary nod to manufacture and market its drug , Sildenafil Citrate. The status quo is a tentative nod for the company to produce 25 mg, 50 mg, and 100 mg of the considered tablet.Viagra is the brand name for Sildenafil Citrate.
As the name suggests, the drug is used to treat erectile dysfunction and pulmonary arterial hypertension. Aurobindo Pharma is a leading name in the Indian pharmaceutical industry with a sound product portfolio comprising CVS, CNS, Anti-Retroviral, Antibiotics, Gastroenterologicals, Anti-Diabetics and Anti-Allergic. The company also has its manufacturing facilities duly inspected by the USFDA as per the standard norms followed by the regulator.
Aurobindo Pharma has crossed the first line, receiving a tentative approval from the US Food and Drug Administration a temporary nod to manufacture and market its drug , Sildenafil Citrate. The status quo is a tentative nod for the company to produce 25 mg, 50 mg, and 100 mg of the considered tablet.Viagra is the brand name for Sildenafil Citrate.
As the name suggests, the drug is used to treat erectile dysfunction and pulmonary arterial hypertension. Aurobindo Pharma is a leading name in the Indian pharmaceutical industry with a sound product portfolio comprising CVS, CNS, Anti-Retroviral, Antibiotics, Gastroenterologicals, Anti-Diabetics and Anti-Allergic. The company also has its manufacturing facilities duly inspected by the USFDA as per the standard norms followed by the regulator.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.